Authors: De Jager P, Chirwa T, Naidoo S, Perovic O, Thomas J
Source: PLOS ONE. 2015 Apr 24;10(4)
Objective: New Dehli metallo-β-lactamase (NDM)-producing Gram-negative bacteria have spread globally and pose a significant public health threat. There is a need to better define risk factors and outcomes of NDM-1 clinical infection. We assessed risk factors for nosocomial infection with NDM-1-producers and associated in-hospital mortality.
Methods: A matched case-control study was conducted during a nosocomial outbreak of NDM-1-procuders in an adult intensive care unit (ICU) in South Africa. All patients from whom NDM-1-producers were identified were considered (n=105). Cases included patients admitted during the study period in whom NDM-1 producing Gram-negative bacteria were isolated from clinical specimens collected ≥48 hours after admission, and where surveillance definitions for healthcare-associated infections were met. Controls were matched for age, sex, date of hospital admission and intensive-care admission. Conditional logistic regression was used to identify risk factors for NDM-1 clinical infection and associated in-hospital mortality.
Findings: 38 cases and 68 controls were included. Klebsiella pneumonia was the most common NDM-1-producer (28/38, 74%). Cases had longer mean hospital stays (44.0 vs. 13.3 days; P<0.001) and ICU stays (32.5 vs. 8.3 days; P<0.001). Adjusting for co-morbid disease, the in-hospital mortality of cases was significantly higher than control (55.3% vs. 14.7%; AOR, 11.29; P<0.001). Higher Charlson co-morbidity index score (5.2 vs. 4.1; AOR, 1.59; P = 0.005), mechanical ventilation days (7.47 vs. 0.94 days; AOR, 1.32; P= 0.003) and piperracillin/ tazobactam exposure (11.03 vs. 0.94 days; AOR, 1.32; P= 0.013) were identified as risk factors on multivariate analysis. Cases had a significantly higher likelihood of in-hospital mortality when the NDM-1-producer was Klebsiella pneumonia (AOR, 16.57; P = 0.007), or when they had a bloodstream infection (AOR, 8.84; P = 0.041).
Conclusion: NDM-1 infection is associated with significant in-hospital mortality. Risk factors for hospital-associated infection include the presence of co-morbid disease, mechanical ventilation and piperacillin/tazobactam exposure.